
About Apotex Pharmachem India
Apotex Pharmachem India is a Healthcare company based in Bengaluru (India) founded in 2003. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. It operates on a B2B model. The company has 136 employees. Apotex Pharmachem India has completed 1 acquisition, including CanPrev. Its focus areas include Pharmaceuticals, Drug Manufacturing and Generic and Biosimilar Medicines.
Company details
Apotex Pharmachem India, founded in 2003 in Bengaluru, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and generic and biosimilar medicines. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Bengaluru, India
- Employees 136
- SectorsHealthcare
- Website apotex.co.in
- Employee Count136
- Investments & Acquisitions
Associated legal entities of Apotex Pharmachem India
Apotex Pharmachem India is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apotex Pharmachem India Private Limited CIN U24231KA2003PTC032104 | Active | 16 Jun 2003 | Bangalore, Karnataka | ₹142 Cr | 209 | 4 | View details |
| Apotex Research Private Limited CIN U73100KA2003PTC032103 | Active | 16 Jun 2003 | Jigani Hobli, Karnataka | ₹727 Cr | 1,236 | 5 | View details |
Board of directors of Apotex Pharmachem India
The boards of the 2 registered companies of Apotex Pharmachem India currently have 6 directors; the longest-serving is Yoganjaneya Reddy Panem, appointed in 2015. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yoganjaneya Reddy Panem DIN 02073863 | Director | 09 Jun 2015 | 11 yrs 4 mo | Apotex Pharmachem India Private Limited |
| Goutam Vilas Pujari DIN 02891339 | Director | 01 Dec 2018 | 7 yrs 10 mo | Apotex Research Private Limited |
| Brian George Mcclelland DIN 06568789 | Director | 15 Sep 2023 | 3 yrs 1 mo | Apotex Research Private Limited, Apotex Pharmachem India Private Limited |
| Kajal Palan DIN 10546962 | Additional Director | 03 May 2024 | 2 yrs 5 mo | Apotex Pharmachem India Private Limited |
| Rajesh Salwan DIN 07669286 | Additional Director | 18 Mar 2025 | 1 yr 7 mo | Apotex Research Private Limited |
| Uta Kellermann Renton DIN 10993254 | Additional Director | 18 Mar 2025 | 1 yr 7 mo | Apotex Research Private Limited, Apotex Pharmachem India Private Limited |
Financials of Apotex Pharmachem India
Figures of Apotex Research Private Limited, the primary company behind Apotex Pharmachem India, for FY 2025. Revenue was ₹727 Cr (+22% year on year). Net profit was ₹76.62 Cr (11% margin). EBITDA was ₹149 Cr (20% margin). Revenue has grown at a compounded annual rate of +10% over three years and +3% over five years.
- ₹727 CrRevenue · FY 2025 · +22% YoY
- ₹76.62 CrNet profit · 11% margin
- ₹149 CrEBITDA · 20% margin
- ₹292 CrPaid-up capital
- 1,236Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Apotex Research Private Limited are on its company page.
Detailed financial statements for Apotex Pharmachem India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apotex Pharmachem India
Apotex Pharmachem India has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CanPrev.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Health Canada-licensed natural health products are manufactured in Canada. | canprev.com | Canada | 0 | Feb 2025 | β’β’β’β’ |
Complete acquisition details for Apotex Pharmachem India
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Apotex Pharmachem India
2 dated milestones of Apotex Pharmachem India across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Apotex Pharmachem India is founded.
- Acquisition Acquires CanPrev.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apotex Pharmachem India
Apotex Pharmachem India was founded in 2003.
Apotex Pharmachem India is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Apotex Pharmachem India has 136 employees.
Apotex Pharmachem India, founded in 2003 in Bengaluru, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and generic and biosimilar medicines. Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Apotex Pharmachem India has made 1 acquisition, including CanPrev.
Apotex Pharmachem India is associated with 2 legal entities: Apotex Research Private Limited, Apotex Pharmachem India Private Limited.
The legal entities of Apotex Pharmachem India currently have 7 directors, including Brian George Mcclelland, Rajesh Salwan, Goutam Vilas Pujari and others.